General Information of Disease (ID: DIS78HM9)

Disease Name Breast-ovarian cancer, familial, susceptibility to, 2
Synonyms
ovarian cancer, familial, susceptibility to, 2; breast cancer, familial, susceptibility to, 2; susceptibility to familial breast-ovarian cancer 2; BROVCA2; BRCA2 hereditary breast ovarian cancer syndrome; breast-ovarian cancer, familial, 2; breast-ovarian cancer, familial, susceptibility to, 2; breast-ovarian cancer, familial, susceptibility to, type 2; hereditary breast ovarian cancer syndrome caused by mutation in BRCA2
Definition Any hereditary breast ovarian cancer syndrome in which the cause of the disease is a mutation in the BRCA2 gene.
Disease Hierarchy
DISHJXS0: Breast-ovarian cancer, familial, susceptibility to
DIS98MYE: Inherited disease susceptibility
DIS78HM9: Breast-ovarian cancer, familial, susceptibility to, 2
Disease Identifiers
MONDO ID
MONDO_0012933
UMLS CUI
C2675520
OMIM ID
612555
MedGen ID
382625

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BRCA2 TTUARD6 Definitive Autosomal dominant [1]
BRCA2 TTUARD6 Definitive CausalMutation [2]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
BRCA2 OTF1XSV1 Definitive Autosomal dominant [1]
------------------------------------------------------------------------------------

References

1 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
2 Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.Hum Mutat. 2019 Sep;40(9):1557-1578. doi: 10.1002/humu.23818.